Clinical trial
Study to Assess the Safety, Tolerability and Pharmacokinetics (PK) of MK-8892 in Participants With Pulmonary Arterial Hypertension (PAH) (MK-8892-005)
This study will evaluate the safety, tolerability, and PK of MK-8892 in participants with pulmonary arterial hypertension
Category | Value |
---|---|
Study start date | 2013-08-19 |